BG
XBIT icon

BlackRock Group’s XBiotech XBIT Stock Holding History

BlackRock Group’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$29K Buy
+2,898
New +$38.6K ﹤0.01% 2950

Other funds holding XBIT

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

BlackRock Group's XBIT Position: Q4 2016 in Review

BlackRock Group opened a new position in XBiotech (XBIT) in Q4 2016: 2,898 shares worth $29K. The stake represents ﹤0.01% of the portfolio and ranks #2950 among its holdings.

49 funds tracked by Wall St. Rank hold XBIT as of Q4 2016.

  • BlackRock Group held 2,898 shares of XBiotech worth $29K as of Q4 2016.
  • XBiotech was a new BlackRock Group position in Q4 2016.
  • XBiotech made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2950 holding.
  • 49 funds tracked by Wall St. Rank held XBiotech as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.